Skip to main content

BUILT DNA

BUILT Biotechnologies provides DNA Manufacturing-as-a-Service, delivering ready-to-use, sequence-perfect DNA constructs in linear and plasmid formats. The company's Regenerative DNA Assembly™ platform reuses validated fragments to reduce costs and lead times, eliminating the need for in-house assembly. Serving biopharma, academic core facilities, and startups, BUILT supports applications including cell and gene therapy, RNA therapeutics, and synthetic biology.

Charlottesville, United States · HQ
Founded 202317500+ followers
Updated 9 days ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Researchers and companies in genome engineering and synthetic biology often spend significant time and resources assembling DNA fragments or sourcing them piecemeal, creating bottlenecks in development. The lack of a reliable, fast, and cost-effective supply of ready-to-use, sequence-perfect DNA molecules slows down research and therapeutic development.

Solution

BUILT Biotechnologies offers a DNA Manufacturing-as-a-Service platform that delivers ready-to-use molecules, eliminating the need for in-house assembly. Powered by its Regenerative DNA Assembly™ technology and a growing inventory of validated fragments, the company provides four product types: clonal plasmid DNA, whole-plasmid synthesis, sequence-perfect linear DNA, and pooled plasmid libraries. This approach ensures high fidelity, with zero build failures to date, and provides a domestic supply chain for reliable access. The service is designed to accelerate development timelines for a range of life science applications.

Target Audience

Primary customers are biopharmaceutical companies, academic core facilities, and startups with large-scale DNA construction needs for cell and gene therapy, RNA therapeutics, and synthetic biology.

Features

  • Regenerative DNA Assembly™ platform that reuses validated fragments to reduce cost and lead times
  • Four product types: Clonal plasmid DNA, Whole-Plasmid Synthesis, Sequence-Perfect Linear DNA, and Pooled Plasmid Libraries
  • Capability to construct long and complex "unbuildable" DNA molecules with high fidelity
  • Secure ordering portal with the ability to reserve manufacturing capacity
  • Serves a range of customers, from top-10 biopharma to university core facilities
This profile is AI-generated and may contain inaccuracies.